ACE Inhibitors with Thiazides Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
ACE inhibitors with thiazides is a combination medicine. ACE inhibitors with thiazides contain a thiazide and an inhibitor that converts angiotensin an enzyme (ACE inhibitor). ACE inhibitor inhibits the conversion of angiotensin enzyme which converts angiotensin I to angiotensin II. ACE inhibitors reduces the angiotensin II level. Decrease in angiotensin II level causes widening of arteries which in turn lowers blood pressure. Thiazide diuretics reduce the active reabsorption of chloride and sodium ions. This reduction of ions is possible by the inhibition of chloride or sodium co-transporter in the distal convoluted tubule. This increases production of urine (diuresis) and helps in reduction of blood volume which in turn lowers blood pressure.
ACE inhibitors with thiazides drugs are used in the treatment of high blood pressure and heart failure. High or raised blood pressure is also called hypertension. It is a non-communicable disease. The blood vessels carry blood to all parts of the body. The heart beat helps in pumping the blood into blood vessels. High blood pressure is caused due to the force of blood that pushes against the artery walls due to the pumping of the heart. The heart has to pump blood harder if the blood pressure is high. Heart failure refers to the heart that is weak and is not able to supply sufficient blood to the cells. This results in shortness of breath, fatigue, and in some cases coughing. Heart failure makes daily activities such as carrying groceries, climbing stairs, or walking difficult.
Increase in heart attacks, high blood pressure, and coronary artery disease are factors driving the global ACE inhibitors with thiazides drugs market. According to the World Heart Failure Alliance, nearly 26 million people live with heart failure across the world. Rise in prevalence of hypertension globally is a major factor propelling the global ACE inhibitors with thiazides drugs market. According to the World Health Organization (WHO), complications of hypertension account for 9.4 million deaths globally each year. Increase in geriatric population leads to high prevalence of hypertension which in turn augments the global ACE inhibitors with thiazides drugs market. The WHO also states that large number of population in low- and middle-income countries are affected by cardiovascular diseases. Increasing physical inactivity and lack of exercise, alcohol addiction, and poor management of stress drive the global ACE inhibitors with thiazides drugs market.
The global ACE inhibitors with thiazides drugs market can be segmented based on molecule type, disease type, distribution channel, and region. In terms of molecule type, the market can be categorized into hydrochlorothiazide / lisinopril, hydrochlorothiazide / moexipril, hydrochlorothiazide / quinapril, captopril / hydrochlorothiazide, benazepril / hydrochlorothiazide, fosinopril / hydrochlorothiazide, and enalapril / hydrochlorothiazide. Based on disease type, the global ACE inhibitors with thiazides drugs market can be classified into heart failure, and hypertension. In terms of distribution channel, the market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies.
Geographically, the global ACE inhibitors with thiazides drugs market can be segmented into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest market share in 2016 owing to high prevalence of hypertension. According to the WHO, 20% to 40% of the adult population, nearly 250 million people, in the region is affected by hypertension. Europe held the second largest market share in 2016 due to increase in geriatric population. The market in Asia Pacific is anticipated to experience strong growth during the forecast period. According to the WHO, delay in diagnosis, and limited access to treatment resulting in poorer health outcomes lead to high prevalence of hypertension which drives the market in the region. The market in Middle East & Africa is expected to witness strong growth during the forecast period due to increasing government initiatives in the region.
Key players in the global ACE inhibitors with thiazides drugs market include AstraZeneca, Mylan Pharmaceuticals Inc., UCB S.A., and Pfizer, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017